Evan Seigerman, BMO Capital Markets, joins ‘Fast Money’ to talk new headwinds facing the pharma sector.
Source link
Trending
- Why U.S. air traffic control is under strain
- Figma launches premium Figma Make ‘vibe-coding’ AI software designer
- Want to Be a Deep Sea Explorer? Don’t Worry, There’s Lots Left.
- Stocks making the biggest moves midday: GOOGL, DIS, ANET, SMCI
- Disney shares surge on earnings beat and many more positive things to like
- Disney’s beat-and-raise quarter has analysts upbeat about further gains
- Used vehicle prices jump to highest level since 2023 amid auto tariffs
- U.S. wanted trade talks, opposes Trump tariffs
Pharma sector still investible, faces added headwinds, says BMO's Seigerman
